The release of cytokines by macrophages is not affected by myelin ingestion

GLIA

Volumn 58, Issue 16, 2010, Pages 1928-1936

  Glim, J E ^a   Vereyken, E J F ^a   Heijnen, D A M ^a   Garcia Vallejo J J ^a   Dijkstra, C D ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Foamy macrophages; LPS contamination; Multiple sclerosis; Polymyxin B

Indexed keywords

CYTOKINE; INTERLEUKIN 10; LIPOPOLYSACCHARIDE; MYELIN; TUMOR NECROSIS FACTOR ALPHA;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; HUMAN; HUMAN CELL; MACROPHAGE; MACROPHAGE ACTIVATION; MULTIPLE SCLEROSIS; PRIORITY JOURNAL;

CELLS, CULTURED; FOAM CELLS; HUMANS; IMMUNOPHENOTYPING; INTERLEUKIN-10; LIPOPOLYSACCHARIDES; MULTIPLE SCLEROSIS; MYELIN SHEATH; PHAGOCYTOSIS; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA;

EID: 78649427989     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.21062     Document Type: Article

References (33)

1. Aron-Wisnewsky J, Tordjman J, Poitou C, Darakhshan F, Hugol D, Basdevant A, Aissat A, Guerre-Millo M, Clement K. 2009. Human adipose tissue macrophages: m1 and m2 cell surface markers in subcutaneous and omental depots and after weight loss. J Clin Endocrinol Metab 94:4619-4623.
2. Barnett MH, Henderson AP, Prineas JW. 2006. The macrophage in MS: Just a scavenger after all? Pathology and pathogenesis of the acute MS lesion. Mult Scler 12:121-132.
3. Boven LA, Van Meurs M, Boot RG, Mehta A, Boon L, Aerts JM, Laman JD. 2004. Gaucher cells demonstrate a distinct macrophage phenotype and resemble alternatively activated macrophages. Am J Clin Pathol 122:359-369.
4. Boven LA, Van Meurs M, Van Zwam M, Wierenga-Wolf A, Hintzen RQ, Boot RG, Aerts JM, Amor S, Nieuwenhuis EE, Laman JD. 2006. Myelin-laden macrophages are anti-inflammatory, consistent with foam cells in multiple sclerosis. Brain 129:517-526.
5. Breij EC, Brink BP, Veerhuis R, van den Berg C, Vloet R, Yan R, Dijkstra CD, van der Valk P, Bo L. 2008. Homogeneity of active demyelinating lesions in established multiple sclerosis. Ann Neurol 63:16-25.
6. Bruck W. 2005. The pathology of multiple sclerosis is the result of focal inflammatory demyelination with axonal damage. J Neurol 252 (Suppl 5):v3-v9.
7. Cumings JN, Shortman RC, Skrbic T. 1965. Lipid studies in the blood and brain in multiple sclerosis and motor neurone disease. J Clin Pathol 18:641-644.
8. Dobrovolskaia MA, Vogel SN. 2002. Toll receptors, CD14, and macrophage activation and deactivation by LPS. Microbes Infect 4:903-914.
9. Erridge C, Samani NJ. 2009. Saturated fatty acids do not directly stimulate toll-like receptor signaling. Arterioscler Thromb Vasc Biol 29:1944-1949.
10. Fujihara M, Muroi M, Tanamoto K, Suzuki T, Azuma H, Ikeda H. 2003. Molecular mechanisms of macrophage activation and deactivation by lipopolysaccharide: roles of the receptor complex. Pharmacol Ther 100:171-194.
11. Hendriks JJ, Teunissen CE, de Vries HE, Dijkstra CD. 2005. Macrophages and neurodegeneration. Brain Res Brain Res Rev 48:185-195.
12. Huitinga I, van Rooijen N, de Groot CJ, Uitdehaag BM, Dijkstra CD. 1990. Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages. J Exp Med 172:1025-1033.
13. Hyka N, Dayer JM, Modoux C, Kohno T, Edwards CK III, Roux-Lombard P, Burger D. 2001. Apolipoprotein A-I inhibits the production of interleukin-1beta and tumor necrosis factor-alpha by blocking contact-mediated activation of monocytes by T lymphocytes. Blood 97:2381-2389.
14. Jacobs DM, Morrison DC. 1977. Inhibition of the mitogenic response to lipopolysaccharide (LPS) in mouse spleen cells by polymyxin B. J Immunol 118:21-27.
15. Jahn O, Tenzer S, Werner HB. 2009. Myelin proteomics: Molecular anatomy of an insulating sheath. Mol Neurobiol 40:55-72.
16. Kim KD, Lim HY, Lee HG, Yoon DY, Choe YK, Choi I, Paik SG, Kim YS, Yang Y, Lim JS. 2005. Apolipoprotein A-I induces IL-10 and PGE2 production in human monocytes and inhibits dendritic cell differentiation and maturation. Biochem Biophys Res Commun 338:1126-1136.
17. Korn T. 2008. Pathophysiology of multiple sclerosis. J Neurol 255 (Suppl 6):2-6.
18. Kornek B, Lassmann H. 2003. Neuropathology of multiple sclerosisnew concepts. Brain Res Bull 61:321-326.
19. Lolmede K, Campana L, Vezzoli M, Bosurgi L, Tonlorenzi R, Clementi E, Bianchi ME, Cossu G, Manfredi AA, Brunelli S, Rovere-Querini P. 2009. Inflammatory and alternatively activated human macrophages attract vessel-associated stem cells, relying on separate HMGB1-and MMP-9-dependent pathways. J Leukoc Biol 85:779-787.
20. Mosser DM, Edwards JP. 2008. Exploring the full spectrum of macrophage activation. Nat Rev Immunol 8:958-969.
21. Murphy AJ, Woollard KJ, Hoang A, Mukhamedova N, Stirzaker RA, McCormick SP, Remaley AT, Sviridov D, Chin-Dusting J. 2008. Highdensity lipoprotein reduces the human monocyte inflammatory response. Arterioscler Thromb Vasc Biol 28:2071-2077.
22. Naito M. 2008. Macrophage differentiation and function in health and disease. Pathol Int 58:143-155.
23. Norton WT, Poduslo SE. 1973. Myelination in rat brain: Method of myelin isolation. J Neurochem 21:749-757.
24. Peake PW, Shen Y, Campbell LV, Charlesworth JA. 2006. Human adiponectin binds to bacterial lipopolysaccharide. Biochem Biophys Res Commun 341:108-115.
25. Raes G, Brys L, Dahal BK, Brandt J, Grooten J, Brombacher F, Vanham G, Noel W, Bogaert P, Boonefaes T, Kindt A, Van den Bergh R., Leenen PJ, De BP, Ghassabeh GH. 2005. Macrophage galactose-type C-type lectins as novel markers for alternatively activated macrophages elicited by parasitic infections and allergic airway inflammation. J Leukoc Biol 77:321-327.
26. Raziuddin S, Morrison DC. 1981. Binding of bacterial endotoxin (LPS) to encephalitogenic myelin basic protein and modulation of characteristic biologic activities of LPS. J Immunol 126:1030-1035.
27. Scanu A, Molnarfi N, Brandt KJ, Gruaz L, Dayer JM, Burger D. 2008. Stimulated T cells generate microparticles, which mimic cellular contact activation of human monocytes: Differential regulation of proand anti-inflammatory cytokine production by high-density lipoproteins. J Leukoc Biol 83:921-927.
28. Turner JJ, Smolinska MJ, Sacre SM, Foxwell BM. 2009. Induction of TLR tolerance in human macrophages by adiponectin: Does LPS play a role? Scand J Immunol 69:329-336.
29. Van der Goes A, Kortekaas M, Hoekstra K, Dijkstra CD, Amor S. 1999. The role of anti-myelin (auto)-antibodies in the phagocytosis of myelin by macrophages. J Neuroimmunol 101:61-67.
30. van der Laan LJ, Ruuls SR, Weber KS, Lodder IJ, Dopp EA, Dijkstra CD. 1996. Macrophage phagocytosis of myelin in vitro determined by flow cytometry: Phagocytosis is mediated by CR3 and induces production of tumor necrosis factor-alpha and nitric oxide. J Neuroimmunol 70:145-152.
31. Weinstein JR, Swarts S, Bishop C, Hanisch UK, Moller T. 2008. Lipopolysaccharide is a frequent and significant contaminant in microglia-activating factors. Glia 56:16-26.
32. Woelk H, Borri P. 1973. Lipid and fatty acid composition of myelin purified from normal and MS brains. Eur Neurol 10:250-260.
33. Zettl UK, Kuhlmann T, Bruck W. 1998. Bcl-2 expressing T lymphocytes in multiple sclerosis lesions. Neuropathol Appl Neurobiol 24:202-208.